KRAS Mutations in Advanced Nonsquamous Non–Small-Cell Lung Cancer Patients Treated with First-Line Platinum-Based Chemotherapy Have No Predictive Value

Autor: Mellema, Wouter W., Dingemans, Anne-Marie C., Thunnissen, Erik, Snijders, Peter J.F., Derks, Jules, Heideman, Daniëlle A.M., Van Suylen, Robertjan, Smit, Egbert F.
Zdroj: In Journal of Thoracic Oncology September 2013 8(9):1190-1195
Databáze: ScienceDirect